SARS-CoV-2 Vaccine Antibody Response in Patients With IBD

被引：0
|
作者：
Garza, Manuel A. [1 ]
Saleh, Adam [2 ]
Maturi, Vamsi [2 ]
Perry, Caroline [1 ]
Cho, Su Min [1 ]
Abraham, Bincy P. [3 ]
机构：
[1] Houston Methodist Hosp, Houston, TX 77030 USA
[2] Texas A&M Hlth Sci Ctr, Coll Med, Houston, TX USA
[3] Houston Methodist Weill Cornell Med Coll, Houston, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S805
引用
收藏
页码：S373 / S373
页数：1
相关论文
共 50 条
  • [31] Antibody response with SARS-CoV-2 inactivated vaccine (CoronaVac) in Turkish geriatric population
    Bas, Arzu Okyar
    Hafizoglu, Merve
    Akbiyik, Filiz
    Oytun, Merve Guner
    Sahiner, Zeynep
    Ceylan, Serdar
    Unsal, Pelin
    Dogu, Burcu Balam
    Cankurtaran, Mustafa
    Cakir, Banu
    Unal, Serhat
    Halil, Meltem Gulhan
    AGE AND AGEING, 2022, 51 (05)
  • [32] Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers
    Heyming, Theodore W.
    Nugent, Diane
    Tongol, Aprille
    Knudsen-Robbins, Chloe
    Hoang, Janet
    Schomberg, John
    Bacon, Kellie
    Lara, Bryan
    Sanger, Terence
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 1 - 6
  • [33] Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia
    Cucunawangsih, Cucunawangsih
    Wijaya, Ratna Sari
    Lugito, Nata Pratama Hardjo
    Suriapranata, Ivet
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 15 - 17
  • [34] Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
    Yue, Lei
    Zhou, Jian
    Zhou, Yanan
    Yang, Xiaolei
    Xie, Tianhong
    Yang, Mengli
    Zhao, Hongling
    Zhao, Yuan
    Yang, Ting
    Li, Hua
    Xiang, Hong
    Wang, Jie
    Lu, Shuaiyao
    Liu, Hongqi
    Zhao, Hong
    Wei, Xingchen
    Zhang, Yuhao
    Xie, Zhongping
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 2125 - 2127
  • [35] Assessment of SARS-CoV-2 specific t-cell response in immunocompromised patients failing to seroconvert in response to sars-cov-2 vaccine
    Wiercinska, E.
    Jarisch, A.
    Daqiq-Mirdad, S.
    Hellstern, H.
    Ajib, S.
    Cremer, A.
    Nguyen, N. T. T.
    Dukat, A.
    Ullrich, E.
    Ciesek, S.
    Chow, K. -U.
    Serve, H.
    Seifried, E.
    Bader, P.
    Boenig, H.
    Bug, G.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 309 - 310
  • [36] Progress on the development of the SARS-CoV-2 vaccine and antibody drugs
    Xu S.
    Tang D.
    Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering, 2022, 39 (05): : 1059 - 1064
  • [37] Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD
    Ray K.
    Nature Reviews Gastroenterology & Hepatology, 2021, 18 (5) : 286 - 286
  • [38] SARS-CoV-2 Vaccine Safety and Autoimmune Response
    Tyan, Yu-Chang
    Chuang, Shih-Chang
    Ho, Tzu-Chuan
    Chuang, Kuo-Pin
    Yang, Ming-Hui
    VACCINES, 2024, 12 (03)
  • [39] THE HUMORAL RESPONSE OF SARS-COV-2 VACCINE IN HAEMODIALYSIS
    Chalkia, Aglaia
    Alexakou, Zoi
    Kourniotis, Dimitrios
    Mpora, Margarita
    Aggelis, George
    Petras, Dimitrios
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I597 - I597
  • [40] Association of Age With SARS-CoV-2 Antibody Response
    Yang, He S.
    Costa, Victoria
    Racine-Brzostek, Sabrina E.
    Acker, Karen P.
    Yee, Jim
    Chen, Zhengming
    Karbaschi, Mohsen
    Zuk, Robert
    Rand, Sophie
    Sukhu, Ashley
    Klasse, P. J.
    Cushing, Melissa M.
    Chadburn, Amy
    Zhao, Zhen
    JAMA NETWORK OPEN, 2021, 4 (03)
12345